Skip to main content
. 2021 Jan 13;104:108–110. doi: 10.1016/j.ijid.2020.12.043

Table 1.

The effects of recombinant tissue plasminogen activator treatment on echocardiographic parameters, respiratory mechanics, blood parameters, and ventilation status.

Echocardiography Before After
SPAP, mmHg 52 40
RV basal diameter, mm 37 36
RV midlevel diameter, mm 35 33
RV end-diastoliс area, cm2 22 20
RA end-systolic area, cm2 17 16.4
TAPSE, mm 18 20
Respiratory mechanics
Rrs, cmH2O/L/s 16 16
Static respiratory system compliance, mL/cmH2O 50 58
R/I ratio 0.38 0.39
Driving pressure, cmH2O 13 12
Blood gas analysis
PaO2/FiO2, mmHg 116 170
PaCO2, mmHg 70 39
pH 7.38 7.43
HCO3, mEq/L 31.6 27.6
Ventilation status
Alveolar dead space, mL 204.3 53.8
Ventilatory ratio 3.73 2.05
Blood analysis
D-dimers, mg/L 53.6 56.3
CRP, mg/L 68 19
Ferritin, ng/mL 2142 1254
ALT, U/L 133 81
AST, U/L 127 60
LDH, U/L 2540 1643

Abbreviations: SPAP = systolic pulmonary arterial pressure, RA = right atrium, RV = right ventricle, TAPSE = tricuspid annular plane systolic excursion, Rrs = respiratory system resistance, R/I = recruitment-to-inflation, PaO2 = partial pressure of oxygen, FiO2 = fraction of inspired oxygen, PaCO2 = partial pressure of carbon dioxide, CRP = C-reactive protein, ALT = alanine transaminase, AST = aspartate transaminase, LDH = lactate dehydrogenase, ventilatory ratio = minute ventilation (mL/min) × PaCO2 (mmHg)/(predicted body weight × 100 × 37.5).